China Shineway Pharmaceutical Group Limited
CSWYF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6,140,153 | $5,888,776 | $725,292 | $659,707 |
| Short-Term Investments | $350,020 | $20,000 | $0 | $0 |
| Receivables | $1,201,877 | $1,324,963 | $149,836 | $135,848 |
| Inventory | $813,190 | $897,709 | $94,520 | $92,226 |
| Other Curr. Assets | $93,283 | $1,348,245 | $1,078,245 | $905,434 |
| Total Curr. Assets | $8,598,523 | $8,154,730 | $974,779 | $893,959 |
| Property Plant & Equip (Net) | $1,219,402 | $1,205,287 | $174,901 | $196,388 |
| Goodwill | $165,956 | $165,956 | $23,852 | $26,032 |
| Intangibles | $23,323 | $32,790 | $30,656 | $36,451 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $34,326 | $15,230 | $2,762 | $3,210 |
| Other NC Assets | $0 | $0 | -$23,852 | -$26,032 |
| Total NC Assets | $1,443,007 | $1,419,263 | $208,319 | $236,049 |
| Other Assets | $0 | -$8,224,427 | $0 | $0 |
| Total Assets | $10,041,530 | $1,349,566 | $1,183,099 | $1,130,008 |
| Liabilities | – | – | – | – |
| Payables | $402,964 | $484,791 | $308,745 | $228,620 |
| Short-Term Debt | $338,271 | $300,971 | $6,530 | $7,587 |
| Tax Payable | $84,270 | $14,930 | $15,492 | $10,211 |
| Deferred Revenue | $0 | $0 | $22,006 | $13,472 |
| Other Curr. Liab. | $1,624,491 | $1,633,026 | $1,334,826 | $851,953 |
| Total Curr. Liab. | $2,449,996 | $2,433,718 | $239,382 | $172,290 |
| LT Debt | $8,256 | $355 | $912 | $7,324 |
| Deferred Rev, NC | $81,853 | $88,888 | $23,568 | $171,594 |
| Deferred Tax Liab, NC | $34,521 | $16,264 | $2,708 | $3,951 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $124,630 | $105,507 | $26,408 | $5,100 |
| Other Liabilities | $0 | -$2,181,291 | $0 | $0 |
| Cap. Leases | $16,527 | $1,326 | $7,442 | $14,911 |
| Total Liabilities | $2,574,626 | $357,934 | $265,790 | $177,390 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $87,662 | $12,357 | $12,599 | $13,751 |
| Retained Earnings | $6,726,436 | $6,326,282 | $833,731 | $841,611 |
| AOCI | $0 | -$69,725 | $93,473 | $94,890 |
| Other Equity | $652,806 | -$5,277,281 | -$4,887,594 | -$24,550 |
| Total Equity | $7,466,904 | $991,633 | $917,309 | $925,702 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $10,041,530 | $1,349,566 | $1,183,099 | $1,130,008 |
| Net Debt | -$5,793,626 | -$5,587,450 | -$717,850 | -$644,796 |